Pharmacoeconomic review report: Glycopyrrolate (Cuvposa) (Medexus pharmaceuticals, inc.) : indication: chronic severe drooling, neurologic (pediatric)
Glycopyrrolate oral solution (Cuvposa) is an anticholinergic drug indicated to reduce chronic severe drooling in patients three to 18 years of age with neurologic conditions (e.g., cerebral palsy [CP]). It is available in a 1 mg/5 mL concentration in 473 mL bottles at a submitted price of $625.00 pe...
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2020, July 2020
|
| Edition: | Version: Final |
| Series: | CADTH common drug review
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references